GlassScriptPhysician profile
Deborah Konkol
NPI 1659395606
$2,428.68
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $298 · 2021: $982 · 2022: $624.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $660.43 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $236.87 | 2021 | |
| Mayne Pharma Commercial LLC | $201.36 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $187.42 | 2022 | |
| Astellas Pharma US INC | $130.04 | 2019 | |
| Lupin INC. | $91.36 | 2019-2021 | |
| Mission Pharmacal Company | $80.47 | 2019-2021 | |
| Therapeuticsmd, INC. | $79.86 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $79.13 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $66.80 | 2019-2021 | |
| Lilly USA, LLC | $65.20 | 2019-2022 | |
| Avion Pharmaceuticals | $63.60 | 2021-2022 | |
| Novo Nordisk INC | $63.46 | 2020 | |
| Evofem Biosciences, INC. | $52.36 | 2021 | |
| Amgen INC. | $52.25 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $44.97 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $43.91 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $42.53 | 2021 | |
| Organon LLC | $35.29 | 2021-2022 | |
| Sage Therapeutics, LLC | $22.19 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.28 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.79 | 2022 | |
| Dysis Medical, INC. | $16.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.44 | 2019 | |
| Gilead Sciences, INC. | $16.05 | 2022 | |
| Daiichi Sankyo INC. | $15.39 | 2022 | |
| Agile Therapeutics, INC. | $12.37 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Konkol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.